To study the beliefs of a group of Canadian men regarding the risks, effectiveness, and importance of routine prostate-specific antigen (PSA) testing when used as a screening tool for prostate cancer.
A 1-page questionnaire designed to gauge patient beliefs about PSA screening.
Two primary care clinics in Kingston, Ont.
Seventy-two men aged 41 to 80.
Whether men believed that the PSA blood test was not risky when used as a screening test for prostate cancer, was effective at preventing death from prostate cancer, and was important for their health.
Fifteen men reported having visited their physicians because of difficulty urinating in the past 2 years, or a personal history of prostate cancer, and were excluded; for these men, the use of the PSA blood test would not be for screening. Of the 57 men considered in the study, 54 (95%) believed that using the PSA blood test as a screening tool for prostate cancer was not risky, 39 (68%) believed that the PSA blood test was good or very good at preventing death from prostate cancer, and 45 (79%) believed that the routine use of the PSA blood test was important or very important for their health. Men in the suggested screening age group of 51 to 70 years (n = 32) had an equally positive impression of PSA screening.
Despite a limited body of evidence showing its effectiveness, Canadian men continue to have a favourable impression of PSA screening and remain largely unaware of potential adverse events associated with PSA testing.
Notes
Cites: Am J Med. 2001 Mar;110(4):309-1311239850
Cites: Fam Pract. 2003 Jun;20(3):294-30312738699
Cites: Prev Med. 2005 Apr;40(4):461-815530599
Cites: J Gen Intern Med. 2006 Mar;21(3):257-916637825
Cites: BMJ. 2010;341:c454320843937
Cites: Ann Intern Med. 2008 Aug 5;149(3):185-9118678845
Cites: N Engl J Med. 2009 Mar 26;360(13):1310-919297565
Cites: N Engl J Med. 2009 Mar 26;360(13):1320-819297566
Cites: Can J Urol. 2010 Feb;17 Suppl 1:18-2520170597